BIOMEDICAL DIAGNOSTICS

BIOMEDICAL DIAGNOSTICS has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.5m and a net result of €339,858. Equity is growing by ~18.3% per year across the filed fiscal years. Its solvency ranks better than 76% of 6,055 sector peers (NACE 46, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).